Breaking News Instant updates and real-time market news.

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02

Adobe says it sees increased demand for PDF capabilities

Says it has over 300,000 Magenta developers. Says it has 14M Behance members. Says investing in high-impact campaign for document business.

  • 15

    Oct

ADBE Adobe
$238.05

-10.84 (-4.36%)

10/12/18
RBCM
10/12/18
NO CHANGE
Target $288
RBCM
Outperform
Adobe's FY19 guidance may top consensus, says RBC Capital
RBC Capital analyst Ross MacMillan kept his Outperform rating and $288 price target on Adobe ahead of its Investor Day, saying there is potential for the company to initiate FY19 guidance that would be higher than consensus, ex-Marketo deal. The analyst notes that earnings and revenue growth expectations of over 20% are possible, though he also sees the impact from adoption of ASC606 and the potential for a lower tax rate as key.
10/11/18
BMOC
10/11/18
NO CHANGE
Target $295
BMOC
Outperform
Adobe's Creative Cloud market to grow 17% per year, says BMO Capital
BMO Capital analyst Keith Bachman kept his Outperform rating and $295 price target on Adobe after his "bottom-up" analysis of the total addressable market of its Creative Cloud business. The analyst sees annualized market growth of 17% through 2021, driven by the expansion of enterprise and consumer users as well as the increase in the average revenue per user. Bachman also projects a 22% annualized revenue growth for Adobe's Creative Cloud in 2019 while anticipating a "durable" high-teen growth rate in the following two years, which he expects to further support the stock.
10/11/18
JPMS
10/11/18
NO CHANGE
JPMS
JPMorgan lists stand outs in Software Technology following recent selloff
The recent pullback in Software Technology stocks has not discriminated in terms of valuation, JPMorgan analyst Sterling Auty tells investors in a research note titled "Our Expected Pullback Finally Arrives." The analyst says he's seen similar selloffs in both his highest valuation stocks and even his lowest. Auty recommends "only nibbling" here and waiting for the next three to five trading sessions to see if it posts any big down days like we saw yesterday "to flush out any remaining volatility." Investors should not try to bottom pick stocks, but rather average into positions to smooth out some of the volatility, the analyst recommends. He views Adobe (ADBE), Ansys (ANSS), Aspen Technology (AZPN), DocuSign (DOCU), Guidewire (GWRE), Intuit (INTU), ServiceNow (NOW), Q2 Holdings (QTWO), Palo Alto Networks (PANW), VeriSign (VRSN) and Veeva (VEEV) as stand outs in Software Technology following the recent pullback.
10/10/18
FBCO
10/10/18
NO CHANGE
Target $300
FBCO
Outperform
User conference should reinforce Adobe's positioning, says Credit Suisse
Credit Suisse analyst Brad Zelnick anticipates Adobe's user conference and accompanying analyst day next week will reinforce Adobe's positioning as a best-of-breed digital creative, experience and marketing vendor. The analyst expects management to elaborate on Adobe's product and go-to market strategy surrounding Experience Cloud given the recent acquisitions of Magento and Marketo. Zelnick estimates Marketo is likely to be neutral to FY19 NG EPS, as he believes there will be minimal DR write-down given the invoicing mix. Adobe should also provide preliminary financial guidance for FY19 total revenue, segment revenue, EPS, and Digital Media ARR, he contends. The analyst reiterates an Outperform rating and $300 price target on the shares.

TODAY'S FREE FLY STORIES

CIT

CIT Group

$45.65

1.36 (3.07%)

06:47
10/22/19
10/22
06:47
10/22/19
06:47
Earnings
CIT Group reports Q3 EPS $1.50, consensus $1.21 »

Reports Q3 revenue $454M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

GPK

Graphic Packaging

$14.86

0.205 (1.40%)

06:44
10/22/19
10/22
06:44
10/22/19
06:44
Earnings
Graphic Packaging reports Q3 EPS 20c, consensus 19c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

06:44
10/22/19
10/22
06:44
10/22/19
06:44
Hot Stocks
Biogen soars 20% on plans to pursue Alzheimer's approval after FDA talks »

Shares of Biogen are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HLX

Helix Energy

$8.32

0.31 (3.87%)

06:43
10/22/19
10/22
06:43
10/22/19
06:43
Earnings
Helix Energy narrows FY19 revenue view to $730M-$760M from $700M-$760M »

Consensus is $749.91M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 14

    Nov

PNTG

The Pennant Group

$18.37

0.19 (1.05%)

06:43
10/22/19
10/22
06:43
10/22/19
06:43
Initiation
The Pennant Group initiated  »

The Pennant Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEBO

Peoples Bancorp

$32.28

0.57 (1.80%)

06:42
10/22/19
10/22
06:42
10/22/19
06:42
Earnings
Peoples Bancorp reports Q3 EPS 72c, consensus 70c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 04

    Dec

  • 05

    Dec

ACRS

Aclaris Therapeutics

$1.40

-0.205 (-12.77%)

06:41
10/22/19
10/22
06:41
10/22/19
06:41
Upgrade
Aclaris Therapeutics rating change  »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

FITB

Fifth Third

$28.04

0.71 (2.60%)

06:40
10/22/19
10/22
06:40
10/22/19
06:40
Hot Stocks
Fifth Third sees Q4 NII down about 1% from Q3, NIM down 4-5bps »

Sees FY19 NII up about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

ARCH

Arch Coal

$78.98

-0.1 (-0.13%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Hot Stocks
Arch Coal backs FY19 total sales volume view 86.7- 92.1 tons »

"We are confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HAS

Hasbro

$120.11

-1.78 (-1.46%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Hot Stocks
Hasbro CEO says 'on track to deliver profitable revenue growth in 2019' »

"Hasbro remains on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

CVNA

Carvana

$77.23

3.42 (4.63%)

06:39
10/22/19
10/22
06:39
10/22/19
06:39
Recommendations
Carvana analyst commentary  »

Carvana sold 15,239…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCH

Arch Coal

$78.98

-0.1 (-0.13%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Earnings
Arch Coal reports Q3 EPS $6.34, consensus $3.39 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ARES

Ares Management

$28.28

0.42 (1.51%)

, NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Hot Stocks
Ares Management sells ownership in Meade Pipeline to NextEra Energy Partners »

Ares Management (ARES)…

ARES

Ares Management

$28.28

0.42 (1.51%)

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

  • 04

    Dec

KOOL

Cesca Therapeutics

$5.31

-0.14 (-2.57%)

06:37
10/22/19
10/22
06:37
10/22/19
06:37
Hot Stocks
Cesca Therapeutics forms JV with Healthbanks Biotech »

Cesca Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$223.57

3.52 (1.60%)

06:36
10/22/19
10/22
06:36
10/22/19
06:36
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to offer access to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BIIB

Biogen

$223.57

3.52 (1.60%)

06:36
10/22/19
10/22
06:36
10/22/19
06:36
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen: Analysis of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SNV

Synovus

$36.30

1.005 (2.85%)

06:35
10/22/19
10/22
06:35
10/22/19
06:35
Earnings
Synovus reports Q3 adjusted EPS 97c, consensus 99c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

, ESALY

Eisai

$0.00

(0.00%)

06:35
10/22/19
10/22
06:35
10/22/19
06:35
Hot Stocks
Biogen plans aducanumab BLA in early 2020 based on FDA talks »

Biogen (BIIB) and Eisai…

BIIB

Biogen

$223.57

3.52 (1.60%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FBC

Flagstar Bancorp

$38.72

0.39 (1.02%)

06:34
10/22/19
10/22
06:34
10/22/19
06:34
Earnings
Flagstar Bancorp reports Q3 EPS $1.11, consensus $1.04 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

BIIB

Biogen

$223.57

3.52 (1.60%)

, ESALY

Eisai

$0.00

(0.00%)

06:34
10/22/19
10/22
06:34
10/22/19
06:34
Hot Stocks
Breaking Hot Stocks news story on Biogen, Eisai »

Biogen plans aducanumab…

BIIB

Biogen

$223.57

3.52 (1.60%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

UBS

UBS

$11.53

0.18 (1.59%)

06:33
10/22/19
10/22
06:33
10/22/19
06:33
Periodicals
UBS to address client overcharges in Singapore, Hong Kong, Reuters reports »

UBS is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

FITB

Fifth Third

$28.04

0.71 (2.60%)

06:33
10/22/19
10/22
06:33
10/22/19
06:33
Earnings
Fifth Third reports Q3 EPS 71c with items, consensus 73c »

Reported results included…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

VRTX

Vertex

$183.73

7.49 (4.25%)

06:32
10/22/19
10/22
06:32
10/22/19
06:32
Recommendations
Vertex analyst commentary  »

Vertex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Mar

PHM

PulteGroup

$38.24

-0.08 (-0.21%)

06:32
10/22/19
10/22
06:32
10/22/19
06:32
Hot Stocks
PulteGroup reports Q3 unit backlog up 4% to 11,638 Homes »

Reports Q3 backlog value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

  • 07

    Nov

PHM

PulteGroup

$38.24

-0.08 (-0.21%)

06:31
10/22/19
10/22
06:31
10/22/19
06:31
Earnings
PulteGroup reports Q3 EPS 99c, consensus 92c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.